Encompass Health Corporation Common Stock (EHC) is a publicly traded Healthcare sector company. As of May 21, 2026, EHC trades at $105.99 with a market cap of $10.53B and a P/E ratio of 17.35. EHC moved +1.20% today. Year to date, EHC is -1.61%; over the trailing twelve months it is -12.93%. Its 52-week range spans $87.85 to $127.99. Analyst consensus is strong buy with an average price target of $141.25. Rallies surfaces EHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EHC recently traded at $105.99. Market cap is $10.53B. P/E ratio is 17.35. Revenue is $6.07B.
| Metric | Value |
|---|---|
| Price | $105.99 |
| Market Cap | $10.53B |
| P/E Ratio | 17.35 |
| EPS | $6.08 |
| Dividend Yield | 0.19% |
| 52-Week High | $127.99 |
| 52-Week Low | $87.85 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.07B |
| Net Income | $810.80M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.94B | $759.10M | $5.62 |
| 2024 | $5.37B | $596.60M | $4.53 |
| 2023 | $4.80B | $463.00M | $3.51 |
| 2022 | $4.35B | $365.90M | $2.72 |
6 analysts cover EHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $141.25.